Lp-PLA2 Inhibition-The Atherosclerosis Panacea?
Based on the complex pathophysiology of atherosclerosis, a large number of biomarkers that relate to lipids, inflammation, immunity, thrombosis and hemostasis, have been investigated experimentally, in epidemiologic studies and in clinical trials. Interest focuses on their potential role to aid in r...
Saved in:
Main Authors: | Mahir Karakas (Author), Wolfgang Koenig (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amstirdam coffee ameliorates Lp-PLA2 and the inflammatory response in an atherosclerosis rats
by: Wirdatun Nafisah, et al.
Published: (2024) -
Lp(a) and inflammation: a new insight into atherosclerosis
by: Hangyu Pan, et al.
Published: (2023) -
Lipoprotein-associated phospholipase A2 (Lp-PLA2) - possible diagnostic and risk biomarker in chronic ischaemic heart disease
by: Adriana Diaconu, et al.
Published: (2021) -
The Relationship Between the Level of Serum ESM‐1 and Lp‐PLA2 in Patients With Acute ST‐Segment Elevation Myocardial Infarction
by: Peng Wei, et al.
Published: (2021) -
The standard aqueous stem bark extract of Mangifera indica L. inhibits toxic PLA2 - NN-XIb-PLA2 of Indian cobra venom
by: Bhadrapura Lakkappa Dhananjaya, et al.
Published: (2016)